Skip to content

Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy:A Prospective Randomized Controlled Study

Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy:A Prospective Randomized Controlled Study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077531
Enrollment
Unknown
Registered
2023-11-11
Start date
2023-11-20
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy

Interventions

Group C:Sham-Remote Ischemic Conditioning (at the time points of 30 min before anesthesia, 30 min after surgery, the morning of the postoperative day 1, the afternoon of the postoperative day 1, the m
Group 1:Remote Ischemic Conditioning (at the time points of 30 min before anesthesia, the morning of the postoperative day 1, the morning of the postoperative day 2): Three cycles (30 minutes), each c
Group 2:Remote Ischemic Conditioning (at the time points of 30 min before anesthesia, 30 min after surgery, the morning of the postoperative day 1, the afternoon of the postoperative day 1, the mornin

Sponsors

The Second Affiliated Hospital, Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Patients undergoing hepatectomy under general anesthesia; ? ASA grade of II ~ III; ? Male and female patients, age 25 to 75 years; ? NYHA grade of I ~ III.

Exclusion criteria

Exclusion criteria: ? Patients with limb deformity or peripheral vascular disease affecting upper limb function; ? Patients with a medical history of nervous system, immune system and mental illness; ? Patients who have received hepatectomy in the past, have important organ diseases or have undergone surgical treatment recently; ? Patients who have recently used anti-inflammatory analgesics, anticoagulants, hormone drugs, immunosuppressants, and ATP-sensitive K-channel blockers (KATP); ? Preoperative severe renal insufficiency (serum creatinine > 442 umol/L, with or without serum potassium > 6.5 mmol/L, or the clinician-recognized need for renal replacement therapy), liver insufficiency (Child-Pugh grade C); ? Patients and/or their family members refuse to participate in the program.

Design outcomes

Primary

MeasureTime frame
ALT;

Secondary

MeasureTime frame
AST;TBIL;INR;ALB;TNF-a;MDA;HO-1;NF-?B;HMGB1;Platelet;WBC;Neutrophil granulocyte percentage;Time to gastrointestinal tolerance;Prolonged postoperative ileus;Postoperative complications;

Countries

China

Contacts

Public ContactHe Huang

The Second Affiliated Hospital, Chongqing Medical University

272605765@qq.com+86 137 0838 5559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026